Drugs / R932333
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01597050 Comparator | Aug 2012 → Sep 2013 | discoid lupus erythematosus, systemic lupus erythematosus | Rigel Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | R932333 | “Drug: R932333” NCT01597050 ↗ |